Now that their role in vaccine research is over, 117 chimpanzees in Japan
face an uncertain fate. The chimps were imported in 1975 for a hepatitis B
vaccine programme and are now in a holding facility run by the drug company
Sanwa Kagaku. The company says it can no longer afford the annual £1.5
million upkeep. There are only a few comparable chimp facilities in the world,
and all are government-subsidised. But the Japanese government is reluctant to
take responsibility for the chimps.
To continue reading, today with our introductory offers
Advertisement
More from New ÒÁÈ˾þÃ
Explore the latest news, articles and features
Popular articles
Trending New ÒÁÈ˾þà articles
1
The world's fastest spider tops 3.5 metres per second
2
Where, when and how to watch the 2026 solar eclipse
3
The race to understand how and when Thwaites glacier will collapse
4
Our verdict on The Selfish Gene: An unpopular piece of popular science
5
Babies are born with the neural foundations for maths
6
We’ve uncovered a master gene that switches on human development
7
Humans sleep the least of all apes – is it the secret to our success?
8
This physicist is hunting for the biggest black hole in the universe
9
I have a 100 per cent chance of getting cancer due to a rare gene
10
The best sci-fi novel in 2026 so far – plus 6 other great reads
